Vaccine Therapy Compared With Interferon Alfa in Treating Patients With Stage III Melanoma

Clinical trial NCT00003715 · TERMINATED

Trial details

NCT number: NCT00003715
Sponsor: AVAX Technologies
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma (Skin)

Start date: 1998-12-01
Enrollment: 425

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.